Trinity Biotech (TRIB) Asset Writedowns and Impairment (2021 - 2024)
Trinity Biotech recorded quarterly Asset Writedowns and Impairment of -$962000.0 in Q4 2024, down 115.7% quarter-over-quarter from -$446000.0 in Q2 2024, and down 231.72% year-over-year from $730314.1 in Q1 2024.
Trinity Biotech's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at -$962000.0 for Q4 2024.
- In Q4 2024, Asset Writedowns and Impairment fell 231.72% year-over-year to -$962000.0; the TTM figure through Dec 2024 stood at -$1.7 million (up 95.25% YoY), while the FY2025 annual figure was $2.2 million, up 254.62% from the prior year.
- Asset Writedowns and Impairment came in at -$962000.0 for Q4 2024 at Trinity Biotech, down from -$446000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $2.3 million in Q3 2022 to a low of -$21.6 million in Q3 2023.
- A 4-year average of -$4.2 million and a median of -$919000.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment sank 1983.82% in 2023 and jumped 95.88% in 2024, its largest moves.
- Trinity Biotech's Asset Writedowns and Impairment stood at -$876000.0 in 2021, then slumped by 246.12% to -$3.0 million in 2022, then soared by 90.44% to -$290000.0 in 2023, then plunged by 231.72% to -$962000.0 in 2024.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$962000.0, -$446000.0, and -$290000.0 for Q4 2024, Q2 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -962,000.00 |
| Dec 31, 2024 | -962,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Dec 31, 2023 | -290,000.00 |
| Dec 31, 2023 | -290,000.00 |
| Sep 30, 2023 | -21.63 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -10.82 Mn |
| Jun 30, 2023 | -10.82 Mn |
| Dec 31, 2022 | -3.03 Mn |
| Dec 31, 2022 | -3.03 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | -519,000.00 |
| Jun 30, 2022 | -519,000.00 |
| Dec 31, 2021 | -876,000.00 |
| Dec 31, 2021 | -876,000.00 |
| Jun 30, 2021 | -6.07 Mn |
| Jun 30, 2021 | -6.07 Mn |